Nyxoah SA current report, Q1 FY2024

Nyxoah SA Form 6-K Summary

Business context and reporting period

Nyxoah SA furnished a Form 6-K on January 9, 2024, reporting preliminary and unaudited revenue estimates for the quarter and full year ended December 31, 2023. The company is a Belgian foreign private issuer that files annual reports on Form 20-F.

Financial metrics

  • Fourth-quarter 2023 revenue: Approximately €1.8 million.
  • Full-year 2023 revenue: Approximately €4.3 million.
  • Profit, cash flow, margins, debt, and liquidity: The filing text does not provide clear values.

Changes versus the prior comparable period

The filing does not provide prior-period revenue figures or a quantified year-over-year comparison. Accordingly, the magnitude of any change cannot be determined from the filing text.

Guidance, outlook, risks, and unusual items

  • The reported revenue figures are preliminary, unaudited estimates and remain subject to revision.
  • Final 2023 financial results were to be reported in the company’s Annual Report on Form 20-F.
  • The filing furnishes a January 9, 2024 press release as Exhibit 99.1; the full contents of that release are not included in the provided filing text.

Key facts for investors to verify

  • Verify final fourth-quarter and full-year 2023 revenue in the subsequent Form 20-F.
  • Review the final filing for profitability, operating expenses, cash usage, liquidity, debt, and financial-statement disclosures.
  • Review Exhibit 99.1 for any additional operating metrics, guidance, clinical or commercial updates, and management commentary.